Wells Fargo Upgrades National Health Investors (NHI) to Overweight

Go back to Wells Fargo Upgrades National Health Investors (NHI) to Overweight

Wedbush Upgrades National Health Investors (NHI) to Outperform

February 26, 2024 5:24 AM EST

Wedbush analyst Richard Anderson upgraded National Health Investors (NYSE: NHI) from Neutral to Outperform with a price target of $64.00 (from $57.00).


For an analyst ratings summary and ratings history on National Health Investors... More